vaccinia-tyrosinase vaccine
Term · Oncology and biomedicine · MLC-T-ONC-017440
A vaccine consisting of recombinant vaccinia virus, based on the modified vaccinia virus Ankara (MVA), that encodes the melanoma-associated antigen tyrosinase. Vaccination with vaccinia-tyrosinase may stimulate the host immune system to mount a cytotoxic T-cell response against tumor cells expressing tyrosinase. Tyrosinase is a melanoma-specific differentiation agent that catalyzes the synthesis of the melanin precursor L-3,4-dihydroxyphenylalanine (L-DOPA).
| Identifier | MLC-T-ONC-017440 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | VACTYROS; rV-TYR Vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017440",
"term": "vaccinia-tyrosinase vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine consisting of recombinant vaccinia virus, based on the modified vaccinia virus Ankara (MVA), that encodes the melanoma-associated antigen tyrosinase. Vaccination with vaccinia-tyrosinase may stimulate the host immune system to mount a cytotoxic T-cell response against tumor cells expressing tyrosinase. Tyrosinase is a melanoma-specific differentiation agent that catalyzes the synthesis of the melanin precursor L-3,4-dihydroxyphenylalanine (L-DOPA).",
"synonyms": [
"VACTYROS",
"rV-TYR Vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/vaccinia-tyrosinase-vaccine/"
}
Record 17,059 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.